Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoQ10 - Nutraceuticals World

What are you searching for?

Sign in
Research

CoQ10

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Pre-eclampsia (pregnancy induced hypertension)



Source: Int J Gynaecol Obstet, April 2009;105(1):43-5.

Research: The point of this study was to assess whether supplementation with CoQ10 during pregnancy could reduce the risk of pre-eclampsia. As such, more than 200 women at increased risk of pre-eclampsia were enrolled in this randomized, double-blind, placebo-controlled trial. They were assigned to receive 200 mg of CoQ10 or placebo daily from 20 weeks of pregnancy until delivery. The primary outcome was rate of pre-eclampsia.

Results: Of the 235 women enrolled in the trial, 118 were randomized to receive CoQ10 and 117 received a placebo. A total of 197 (84%) women were followed-up. The overall rate of pre-eclampsia was 20% (n=47). Thirty women (26%) in the placebo group developed pre-eclampsia compared with 17 women (14%) in the CoQ10 group, and this reduction was significant. Thus, researchers concluded that supplementation with CoQ10 may reduce the risk of developing pre-eclampsia in women at risk for the condition.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters